Response of Pharma to the COVID-19 Pandemic: Crisis as an Opportunity
Dr Duncan Emerton
Director, Custom Intelligence and Analytics
Informa Pharma Intelligence
Daniel Chancellor
Director, Thought Leadership
Informa Pharma Intelligence
Response of Pharma to the COVID-19 Pandemic
